IN2012DE00868A - - Google Patents

Download PDF

Info

Publication number
IN2012DE00868A
IN2012DE00868A IN868DE2012A IN2012DE00868A IN 2012DE00868 A IN2012DE00868 A IN 2012DE00868A IN 868DE2012 A IN868DE2012 A IN 868DE2012A IN 2012DE00868 A IN2012DE00868 A IN 2012DE00868A
Authority
IN
India
Prior art keywords
drug
coating composition
time
solid preparation
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Miyuki Fukasawa
Yuichi Nishiyama
Takafumi Hoshino
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45888055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DE00868(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Publication of IN2012DE00868A publication Critical patent/IN2012DE00868A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C09D101/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN868DE2012 2011-03-30 2012-03-23 IN2012DE00868A (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011075344 2011-03-30

Publications (1)

Publication Number Publication Date
IN2012DE00868A true IN2012DE00868A (enrdf_load_stackoverflow) 2015-09-04

Family

ID=45888055

Family Applications (1)

Application Number Title Priority Date Filing Date
IN868DE2012 IN2012DE00868A (enrdf_load_stackoverflow) 2011-03-30 2012-03-23

Country Status (5)

Country Link
US (1) US20120251588A1 (enrdf_load_stackoverflow)
EP (1) EP2510923B1 (enrdf_load_stackoverflow)
JP (1) JP5667113B2 (enrdf_load_stackoverflow)
CN (1) CN102727458B (enrdf_load_stackoverflow)
IN (1) IN2012DE00868A (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5836980B2 (ja) * 2013-01-11 2015-12-24 信越化学工業株式会社 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法
WO2014196519A1 (ja) * 2013-06-03 2014-12-11 信越化学工業株式会社 加熱溶融押出用組成物及びこれを用いた加熱溶融押出成型物の製造方法
JP6203702B2 (ja) * 2014-11-18 2017-09-27 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法
BR112018010354A2 (pt) * 2015-12-08 2018-12-04 Dow Global Technologies Llc composições compreendendo éteres de celulose e éteres de celulose esterificados solúveis em água
US9884922B2 (en) * 2016-03-11 2018-02-06 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate, method for producing the same and composition containing the same
CN105999286A (zh) * 2016-07-11 2016-10-12 成都中牧生物药业有限公司 一种防潮薄膜包衣预混剂及制备方法
CN106138003A (zh) * 2016-07-11 2016-11-23 成都中牧生物药业有限公司 一种稳定型薄膜包衣预混剂及制备方法
CN106075461A (zh) * 2016-07-11 2016-11-09 成都中牧生物药业有限公司 一种遮盖异味的薄膜包衣预混剂及制备方法
JP7050714B2 (ja) * 2019-04-04 2022-04-08 信越化学工業株式会社 腸溶性コーティング用組成物及び固形製剤の製造方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法
US4789549A (en) * 1987-03-09 1988-12-06 Warner-Lambert Company Sustained release dosage forms
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
JPH04202124A (ja) * 1990-11-29 1992-07-22 Fuji Kagaku Kogyo Kk 噴霧乾燥造粒法による薬物放出の制御された製剤の製造法
JPH08143476A (ja) 1994-11-18 1996-06-04 Japan Tobacco Inc 薬物放出制御膜及び固形製剤
JP2000128779A (ja) 1998-10-20 2000-05-09 Mitsui Chemicals Inc 薬物放出制御型製剤
JP4181738B2 (ja) * 2000-08-25 2008-11-19 信越化学工業株式会社 腸溶性コーティング製剤の製造方法
MXPA05004648A (es) 2002-10-30 2005-06-08 Pharmacia Corp Comprimidos orales de liberacion extendida y procedimientos de preparacion y uso de los mismos.
EP1473030B2 (en) * 2003-05-02 2014-05-14 Dexcel Ltd. Extended release Venlafaxine tablet formulation
US7294347B2 (en) * 2004-06-21 2007-11-13 Council Of Scientific And Industrial Research Coating compositions for bitterness inhibition
GB0517205D0 (en) * 2005-08-22 2005-09-28 Novartis Ag Organic compounds
KR100888131B1 (ko) 2006-10-10 2009-03-11 한올제약주식회사 시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
JP2009191034A (ja) 2008-02-15 2009-08-27 Ss Pharmaceut Co Ltd 時限放出製剤
US20110117194A1 (en) * 2008-04-29 2011-05-19 Hanall Biopharma Co., Ltd. Pharmaceutical formulation containing angiotensin-ii receptor blocker

Also Published As

Publication number Publication date
US20120251588A1 (en) 2012-10-04
CN102727458A (zh) 2012-10-17
EP2510923A1 (en) 2012-10-17
JP2012214461A (ja) 2012-11-08
JP5667113B2 (ja) 2015-02-12
CN102727458B (zh) 2015-01-14
EP2510923B1 (en) 2014-12-31

Similar Documents

Publication Publication Date Title
IN2012DE00868A (enrdf_load_stackoverflow)
IL220679A (en) Method of manufacture of solid preparations containing basic active pharmaceutical ingredients and the solid preparations produced by the method
ZA201400386B (en) Process for the preparation of a pharmaceutical composition containing pirfenidone in sustained-release tablet form and its application in the regression of human chronic renal failure, breast capsular contracture and hepatic fibrosis
MX2008011579A (es) Forma galenica divisible que permite una liberacion modificada del principio activo.
MX2014001159A (es) Preparacion de liberacion sostenida de invabradina o sales farmaceuticamente aceptables de la misma.
CO6300903A2 (es) Preparacion de formas farmaceuticas relajantes de musculos esqueleticos de liberacion controlada
MY159492A (en) Solid pharmaceutical formulation with delayed release
IN2014DE00037A (enrdf_load_stackoverflow)
PH12020550806A1 (en) Core tablet composite preparation comprising mosapride and rabeprazole
MD4563B1 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
PH12014502834B1 (en) Pharmaceutical form for extended release of active substances
WO2011141791A3 (en) Extended release formulations of desvenlafaxine base
NZ603199A (en) Orally disintegrating tablet containing acarbose
WO2013017910A8 (en) Extended release pharmaceutical compositions containing paliperidone
WO2012014052A3 (en) Novel coated extended release pharmaceutical compositions containing paliperidone
MX2017012643A (es) Procedimiento de elaboracion de pellets entericos que contienen un inhibidor de la bomba protonica y composiciones farmaceuticas multiparticuladas que los contienen.
UA105285C2 (uk) Тверда фармацевтична композиція раміприлу і безилату амлодипіну і її отримання
HUP1000565A2 (en) Process for the preparation of pharmaceutically active compound and intermediers
JP2013249283A5 (enrdf_load_stackoverflow)
FR2903602B1 (fr) Formulation injectable a liberation prolongee de principes actifs, procede pour sa preparation
WO2012013994A3 (en) Ph-dependent gradual release pharmaceutical composition
WO2011063774A3 (en) Pectin complexes of steroids and pharmaceutical compositions based thereon
WO2011107921A3 (en) Modified release composition of milnacipran
CO6630120A2 (es) Composicion herbicida y procedimiento de uso de la misma